IONIS PHARMACEUT reported $130M in Gross Profit on Sales for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
Alnylam Pharmaceuticals ALNY:US $ 154.97M 35.33M
Astellas Pharma 4503:JP Y 263018M 894M
Biocryst Pharmaceuticals BCRX:US $ 40.38M 9.24M
Biomarin Pharmaceutical BMRN:US $ 305.2M 69.43M
Bluebird Bio BLUE:US $ 2.97M 10.8M
Esperion Therapeutics ESPR:US $ 8.85M 30.01M
Exelixis EXEL:US $ 316.55M 53.74M
Gw Pharmaceuticals GWPH:US $ 140.66M 2.86M
Halozyme Therapeutics HALO:US $ 97.24M 16.2M
Intercept Pharmaceuticals ICPT:US $ 92.17M 3.79M
Moderna Inc MRNA:US 4.25B 643M
Nektar Therapeutics NKTR:US $ 19.61M 1.05M
Neurocrine Biosciences NBIX:US $ 291.8M 6M
Novartis NOVN:VX 9.52B 21M
Omeros OMER:US $ 29.67M 1.19M
Pfizer PFE:US $ 14163M 2178M
Ptc Therapeutics PTCT:US $ 132.2M 22.89M
Regeneron Pharmaceuticals REGN:US $ 2999.6M 1445.2M
Sarepta Therapeutics SRPT:US $ 165.96M 21.39M
Ultragenyx Pharmaceutical RARE:US $ 77.47M 6.37M
Vertex Pharmaceuticals VRTX:US $ 1747.65M 182.25M